OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Farshad Farshidfar, Siyuan Zheng, Marie‐Claude Gingras, et al.
Cell Reports (2017) Vol. 19, Iss. 13, pp. 2878-2880
Open Access | Times Cited: 209
Farshad Farshidfar, Siyuan Zheng, Marie‐Claude Gingras, et al.
Cell Reports (2017) Vol. 19, Iss. 13, pp. 2878-2880
Open Access | Times Cited: 209
Showing 1-25 of 209 citing articles:
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Min Zhang, Hui Yang, Lingfei Wan, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1118-1130
Open Access | Times Cited: 422
Min Zhang, Hui Yang, Lingfei Wan, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1118-1130
Open Access | Times Cited: 422
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma
Lipika Goyal, Lei Shi, Leah Y. Liu, et al.
Cancer Discovery (2019) Vol. 9, Iss. 8, pp. 1064-1079
Open Access | Times Cited: 321
Lipika Goyal, Lei Shi, Leah Y. Liu, et al.
Cancer Discovery (2019) Vol. 9, Iss. 8, pp. 1064-1079
Open Access | Times Cited: 321
Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 353-363
Open Access | Times Cited: 321
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 353-363
Open Access | Times Cited: 321
Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
Sylvie Job, Delphine Rapoud, Alexandre Dos Santos, et al.
Hepatology (2019) Vol. 72, Iss. 3, pp. 965-981
Open Access | Times Cited: 244
Sylvie Job, Delphine Rapoud, Alexandre Dos Santos, et al.
Hepatology (2019) Vol. 72, Iss. 3, pp. 965-981
Open Access | Times Cited: 244
Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 198
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 198
Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids
Benedetta Artegiani, Lisa van Voorthuijsen, Rik G.H. Lindeboom, et al.
Cell stem cell (2019) Vol. 24, Iss. 6, pp. 927-943.e6
Open Access | Times Cited: 185
Benedetta Artegiani, Lisa van Voorthuijsen, Rik G.H. Lindeboom, et al.
Cell stem cell (2019) Vol. 24, Iss. 6, pp. 927-943.e6
Open Access | Times Cited: 185
Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity
Ling Li, Hildur Knútsdóttir, Ken Hui, et al.
JCI Insight (2019) Vol. 4, Iss. 2
Open Access | Times Cited: 181
Ling Li, Hildur Knútsdóttir, Ken Hui, et al.
JCI Insight (2019) Vol. 4, Iss. 2
Open Access | Times Cited: 181
DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis
Antonios Papanicolau‐Sengos, Kenneth Aldape
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 295-321
Closed Access | Times Cited: 179
Antonios Papanicolau‐Sengos, Kenneth Aldape
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 295-321
Closed Access | Times Cited: 179
Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review
Audra Boscoe, Catherine Rolland, Robin Kate Kelley
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 4, pp. 751-765
Open Access | Times Cited: 160
Audra Boscoe, Catherine Rolland, Robin Kate Kelley
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 4, pp. 751-765
Open Access | Times Cited: 160
Current and emerging therapies for advanced biliary tract cancers
Audrey E. Kam, Ashiq Masood, Rachna T. Shroff
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 11, pp. 956-969
Closed Access | Times Cited: 120
Audrey E. Kam, Ashiq Masood, Rachna T. Shroff
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 11, pp. 956-969
Closed Access | Times Cited: 120
Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
Xing Huang, Tianyu Tang, Gang Zhang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 118
Xing Huang, Tianyu Tang, Gang Zhang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 118
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 736-748
Open Access | Times Cited: 90
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 736-748
Open Access | Times Cited: 90
Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 63
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 63
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2017) Vol. 9, Iss. 9, pp. 127-127
Open Access | Times Cited: 144
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2017) Vol. 9, Iss. 9, pp. 127-127
Open Access | Times Cited: 144
Patient Similarity Networks for Precision Medicine
Shraddha Pai, Gary D. Bader
Journal of Molecular Biology (2018) Vol. 430, Iss. 18, pp. 2924-2938
Open Access | Times Cited: 137
Shraddha Pai, Gary D. Bader
Journal of Molecular Biology (2018) Vol. 430, Iss. 18, pp. 2924-2938
Open Access | Times Cited: 137
Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism
Di Yu, Yang Liu, Yiqiang Zhou, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 18, pp. 9964-9972
Open Access | Times Cited: 112
Di Yu, Yang Liu, Yiqiang Zhou, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 18, pp. 9964-9972
Open Access | Times Cited: 112
ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
Ian Y. Luk, Camilla M. Reehorst, John M. Mariadason
Molecules (2018) Vol. 23, Iss. 9, pp. 2191-2191
Open Access | Times Cited: 101
Ian Y. Luk, Camilla M. Reehorst, John M. Mariadason
Molecules (2018) Vol. 23, Iss. 9, pp. 2191-2191
Open Access | Times Cited: 101
Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
Nancy M. Joseph, Christos G. Tsokos, Sarah E. Umetsu, et al.
The Journal of Pathology (2019) Vol. 248, Iss. 2, pp. 164-178
Closed Access | Times Cited: 101
Nancy M. Joseph, Christos G. Tsokos, Sarah E. Umetsu, et al.
The Journal of Pathology (2019) Vol. 248, Iss. 2, pp. 164-178
Closed Access | Times Cited: 101
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice
Jingxiao Wang, Mingjie Dong, Zhong Xu, et al.
Oncogene (2018) Vol. 37, Iss. 24, pp. 3229-3242
Open Access | Times Cited: 99
Jingxiao Wang, Mingjie Dong, Zhong Xu, et al.
Oncogene (2018) Vol. 37, Iss. 24, pp. 3229-3242
Open Access | Times Cited: 99
Lower Grade Gliomas
Gilbert Youssef, Julie J. Miller
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 7
Open Access | Times Cited: 99
Gilbert Youssef, Julie J. Miller
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 7
Open Access | Times Cited: 99
Dissenting degradation: Deubiquitinases in cell cycle and cancer
Thomas Bonacci, Michael J. Emanuele
Seminars in Cancer Biology (2020) Vol. 67, pp. 145-158
Open Access | Times Cited: 92
Thomas Bonacci, Michael J. Emanuele
Seminars in Cancer Biology (2020) Vol. 67, pp. 145-158
Open Access | Times Cited: 92
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
Lucille Stuani, Marie Sabatier, Estelle Saland, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 5
Open Access | Times Cited: 91
Lucille Stuani, Marie Sabatier, Estelle Saland, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 5
Open Access | Times Cited: 91
Evolution of the Experimental Models of Cholangiocarcinoma
Annamaria Massa, Chiara Varamo, Francesca Vita, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2308-2308
Open Access | Times Cited: 89
Annamaria Massa, Chiara Varamo, Francesca Vita, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2308-2308
Open Access | Times Cited: 89
YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity
Takaaki Sugihara, Nathan W. Werneburg, Matthew C. Hernandez, et al.
Molecular Cancer Research (2018) Vol. 16, Iss. 10, pp. 1556-1567
Open Access | Times Cited: 87
Takaaki Sugihara, Nathan W. Werneburg, Matthew C. Hernandez, et al.
Molecular Cancer Research (2018) Vol. 16, Iss. 10, pp. 1556-1567
Open Access | Times Cited: 87
